Human Differential Intelligence, LLC has launched a litigation campaign targeting defendants Bed Bath & Beyond (6:20-cv-00310), CIGNA (6:20-cv-00305), CVS (6:20-cv-00311), and The Gap (6:20-cv-00307) over their websites’ use of the reCAPTCHA v2 CAPTCHA system for user verification. The two asserted patents belong to a family of seven issuing to two named inventors, one of which is identified as Human Differential’s manager. The last campaign to target the use of reCAPTCHA technology went dormant last August, after a suit against Best Buy was dismissed with prejudice from the Southern District of California.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.